Elevate Your Processes: Mass Spectrometry for Fermentation

Can't see this email? View it online

	Biotechnology
	The latest Biotechnology news from AZoNetwork

Elevate Your Processes: Mass Spectrometry for Fermentation

Discover the power of real-time fermentation process tracking with the latest application note.

Thermo Scientific™ Prima Process Mass Spectrometer offers fast, non-invasive analysis of respiratory gases, providing crucial insights into culture physiology, growth kinetics, and substrate consumption. With cutting-edge technology and 21 CFR Part 11 compliant software, it's time to elevate your processes.

Download now to learn more and optimize your fermentation!

Get Your Free App Note

			Game-changing point-of-care assay could revolutionize Mpox detection worldwide Researchers from Australia developed a point-of-care assay for the rapid detection of mpox virus (MPXV) in clinical samples based on isothermal amplification along with clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein (Cas) technology.

			Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal Tiziana Life Sciences Ltd. today announced acceptance of a publication that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD).

	University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study In 2021, the University of Birmingham and Acticor Biotech signed a partnership agreement to evaluate glenzocimab efficacy in myocardial infarction in a new clinical trial called LIBERATE.

	African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

	Research provides key insights into the molecular underpinnings of acute liver injury A team of researchers from Chonnam National University and the Korea Research Institute of Bioscience and Biotechnology unveiled important insights into liver injury and its underlying molecular mechanisms.

	Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by US biopharmaceutical company Nuvectis Pharma, Inc.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions